Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-19

Clinical Trial Update: PMCF Study on the Safety and Performance of CESPACE 3D

View source ↗

Summary

Aesculap AG reports the completion of a PMCF study assessing the safety and performance of the CESPACE 3D device for spinal instability conditions. The study fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CESPACE 3D

Snippet

Sponsor: Aesculap AG | Conditions: Degenerative Instability, Spondylolisthesis | Status: COMPLETED